Condition: Cisplatin Nephrotoxicity · Nephrotoxicity · Sponsor: Minia University
To assess the nephroprotective efficacy of Alpha-Lipoic Acid in preventing cisplatin-induced nephrotoxicity in oncology patients by monitoring renal function changes
This description comes directly from the study's public registry record.
Asmaa Mohammed · 00201090824147 · asmaa.bashandy@mu.edu.eg
Always discuss trial participation with your own doctor first.
| Minia University Hospital | Minya, Minya Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07564479